Chemical Collective

Adderall

29 min · 16 de oct de 2024
Portada del episodio Adderall

Descripción

The discussion on Adderall, a central nervous system stimulant, delved into its classification, mechanisms, and uses. Adderall, an amphetamine, increases dopamine and norepinephrine levels, enhancing focus and attention in individuals with ADHD. Its history dates back to 1887, with significant use in the 1960s for weight loss and since the 1990s for ADHD. Misuse is prevalent, particularly among college students, with up to 30% using it non-medically. Adderall's scheduling as a Schedule II controlled substance reflects its high abuse liability. Long-term effects include neuroplasticity and potential risks for children. The conversation also touched on its off-target effects, such as insomnia and loss of appetite.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Chemical Collective!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

23 episodios

episode Psychedelics: Serotonin, Neuroplasticity, and Holistic Healing artwork

Psychedelics: Serotonin, Neuroplasticity, and Holistic Healing

The discussion delved into the mechanisms of psychedelics, particularly their interaction with serotonin receptors, notably the 5-HT2A receptor. Key researchers like Brian Roth and David Nutt were mentioned. The conversation also explored neuroplasticity, emphasizing that new synapses are not always beneficial and that pruning is crucial. The role of microglia in synaptic pruning and the potential of psychedelics in treating conditions like PTSD and addiction were discussed. The importance of a holistic approach, including diet and environment, was highlighted, contrasting modern Western science with traditional shamanic practices. The need for vulnerability and trust in therapeutic settings was also emphasized.

27 de nov de 202428 min
episode Unraveling Neuroinflammation: Dr. Kendra McLaughlin on Microglia, Biomarkers, and Innovative Therapies for Brain Health artwork

Unraveling Neuroinflammation: Dr. Kendra McLaughlin on Microglia, Biomarkers, and Innovative Therapies for Brain Health

Dr. Kendra McLaughlin, an assistant professor at UNLV, discusses her research on neuroinflammation and microglia, immune cells in the brain. She explains how microglia, which can protect neurons, can also become overactive and harmful under chronic stress or disease, contributing to neurodegenerative conditions like Alzheimer's and Parkinson's. Dr. McLaughlin highlights the importance of early detection through biomarkers and innovative therapies, such as TSPO modulators and cannabinoid-based treatments targeting CB2 receptors. She emphasizes the need for interdisciplinary approaches, including engineering models, to better understand and manage neuroinflammation, aiming for personalized medicine and early intervention to mitigate brain damage.

6 de nov de 202428 min